跳至主要内容
临床试验/NCT03177330
NCT03177330Unknown不适用

Safety and Efficacy of Heparin Dosing Score Protocol for Anticoagulation During Polymyxin-B Hemoperfusion: a Retrospective Study

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年5月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
premature cartridge clotting rate

研究概览

简要总结

Polymyxin B hemoperfusion (PMX-HP) is mainly used to remove endotoxins in septic shock patients with intra-abdominal infections. Because of the concerns of postoperative bleeding, physicians may hesitate to use anticoagulation in patients with septic shock within a few hours after an abdominal operation. We developed a heparin dosing score protocol for heparin dosage adjustment. The purpose of the study is to examine the safety and efficacy of the heparin dosing score protocol.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • intra-abdominal septic shock patients or documented Gram-negative bacterial septic shock patients who received polymyxin-B hemoperfusion in National Taiwan University Hospital during October 2013-December 2016

排除标准

  • pregnant woman
  • patients with do-not-resuscitate declaration
  • uncontrolled bleeding within 24hr

结局指标

主要结局

premature cartridge clotting rate

时间窗: 2 hours

the incidence of premature cartridge clotting within 2hr

次要结局

  • bleeding event rate(24 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Safety and Efficacy of Heparin Dosing Score Protocol... | 临床试验